164 related articles for article (PubMed ID: 8680085)
1. [Locally developed sarcoma of the thoracic wall].
Bui NB; Stöckle E; Coindre JM; Kantor G; Kind M; Thomas L
Bull Cancer; 1996 May; 83(5):335-43. PubMed ID: 8680085
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
3. Management of soft tissue sarcomas of the extremity in adults.
Valle AA; Kraybill WG
J Surg Oncol; 1996 Dec; 63(4):271-9. PubMed ID: 8982374
[TBL] [Abstract][Full Text] [Related]
4. Dana-Farber Cancer Institute studies in advanced sarcoma.
Antman KH; Elias A
Semin Oncol; 1990 Feb; 17(1 Suppl 2):7-15. PubMed ID: 2106162
[TBL] [Abstract][Full Text] [Related]
5. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Demetri GD; Elias AD
Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
[TBL] [Abstract][Full Text] [Related]
6. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
[TBL] [Abstract][Full Text] [Related]
7. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
[TBL] [Abstract][Full Text] [Related]
8. Has "MAID" made it in the management of high-risk soft-tissue sarcoma?
O'Sullivan B; Bell RS
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):915-6. PubMed ID: 12829123
[No Abstract] [Full Text] [Related]
9. The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.
Stoeckle E; Michot A; Rigal L; Babre F; Sargos P; Henriques de Figueiredo B; Brouste V; Italiano A; Toulmonde M; Le Loarer F; Kind M
Eur J Surg Oncol; 2017 Jun; 43(6):1117-1125. PubMed ID: 28202211
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
11. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Antman K; Crowley J; Balcerzak SP; Rivkin SE; Weiss GR; Elias A; Natale RB; Cooper RM; Barlogie B; Trump DL
J Clin Oncol; 1993 Jul; 11(7):1276-85. PubMed ID: 8315425
[TBL] [Abstract][Full Text] [Related]
12. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
13. Alveolar soft part sarcoma: a rare and enigmatic entity.
Anderson ME; Hornicek FJ; Gebhardt MC; Raskin KA; Mankin HJ
Clin Orthop Relat Res; 2005 Sep; 438():144-8. PubMed ID: 16131883
[TBL] [Abstract][Full Text] [Related]
14. [Soft-tissue sarcomas. Review of 47 patients treated in 10 years in the same institute].
Coster B; Schmitz A; Six C; Majois F; Hermans J; Beauduin M
Acta Orthop Belg; 1989; 55(4):557-64. PubMed ID: 2631548
[TBL] [Abstract][Full Text] [Related]
15. Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
Patsner B; Greenberg S
Gynecol Oncol; 1995 Sep; 58(3):386-8. PubMed ID: 7672707
[TBL] [Abstract][Full Text] [Related]
16. Effective local control of advanced soft tissue sarcoma with neoadjuvant chemoradiotherapy and surgery: A single institutional experience.
Stubbe F; Agaimy A; Ott O; Lettmaier S; Vassos N; Croner R; Hohenberger W; Fietkau R; Semrau S
Cancer Radiother; 2016 Feb; 20(1):6-13. PubMed ID: 26700874
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
Pisters PW
J Clin Oncol; 2006 Feb; 24(4):549-51. PubMed ID: 16446327
[No Abstract] [Full Text] [Related]
18. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Bui BN; Chevallier B; Chevreau C; Krakowski I; Peny AM; Thyss A; Maugard-Louboutin C; Cupissol D; Fargeot P; Bonichon F
J Clin Oncol; 1995 Oct; 13(10):2629-36. PubMed ID: 7595717
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Issels RD; Prenninger SW; Nagele A; Boehm E; Sauer H; Jauch KW; Denecke H; Berger H; Peter K; Wilmanns W
J Clin Oncol; 1990 Nov; 8(11):1818-29. PubMed ID: 2121910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
